Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 2, 2011, Pages 345-353

  Chung, Woo Suk ^a   Kim, Myeong Jin ^a   Chung, Yong Eun ^a   Kim, Yeo Eun ^a   Park, Mi Suk ^a   Choi, Jin Young ^a   Kim, Ki Whang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

colorectal; diffusion weighted imaging; gadoxetic acid; liver metastases; MR imaging

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 79960587686     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22671     Document Type: Article

References (31)

1. Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007; 18: 299-304. (Pubitemid 46323097)
2. Bolton JS, Fuhrman GM,. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231: 743-751. (Pubitemid 30249836)
3. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766. (Pubitemid 34547293)
4. Choi JY, Kim MJ, Kim JH, et al. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging. Eur J Radiol 2006; 60: 84-90. (Pubitemid 44397393)
5. Kim YK, Lee JM, Kim CS,. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004; 14: 5-13. (Pubitemid 38181049)
6. Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 2008; 18: 903-910.
7. Onishi H, Murakami T, Kim T, et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006; 239: 131-138.
8. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237: 170-180. (Pubitemid 41346161)
9. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO,. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007; 6: 43-52.
10. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K,. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010; 20: 2690-2698.
11. Ward J,. New MR techniques for the detection of liver metastases. Cancer Imaging 2006; 6: 33-42.
12. Hirokawa Y, Isoda H, Okada T, et al. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration. Invest Radiol 2010; 45: 158-164.
13. Kwee TC, Takahara T,. Diffusion-weighted MRI for detecting liver metastases: importance of the b-value. Eur Radiol 2011; 21: 150.
14. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130.
15. Bruegel M, Rummeny EJ,. Hepatic metastases: use of diffusion-weighted echo-planar imaging. Abdom Imaging 2010; 35: 454-461.
16. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 2010; 20: 1431-1441.
17. Hekimoglu K, Ustundag Y, Dusak A, et al. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Eur J Radiol 2011; 77: 468-472.
18. Soyer P, Boudiaf M, Place V, et al. Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol 2010 Jul 20. [Epub ahead of print].
19. Löwenthal D, Zeile M, Lim WY, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 2011; 21: 832-840.
20. Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B,. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 2011; 33: 128-135.
21. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80: 524-531. (Pubitemid 47343080)
22. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28: 691-697.
23. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW,. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010; 20: 1052-1060.
24. Saito K, Araki Y, Park J, et al. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2010; 32: 229-234.
25. Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG,. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T2 weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 2010 [Epub ahead of print].
26. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252: 247-254.
27. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y,. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226: 71-78. (Pubitemid 36163910)
28. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246: 812-822.
29. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J Radiol 2010; 76: 89-95.
30. Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010; 32: 138-147.
31. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM,. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009; 16: 1208-1214.